Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company ...

(Reuters) -Kenvue cut its annual sales forecast on Thursday, as the consumer health company undergoes a strategic review aiming to boost brand performance amid a cautious spending environment. The ...

Burn your hand on a hot stove and, almost instantly, immune cells within the wound begin producing inflammatory compounds to help clear out dead tissue and fight off infection. In most cases, the ...

Making ends meet has become a daily struggle for millions of families in Malaysia owing to the rise of living costs and surge in inflation. One of the worst hit segments are families in the B40 group- ...

Kenvue cuts 2025 sales forecast Says strategic review continues to advance Analysts see Kenvue as potential acquisition target Aug 7 (Reuters) - Kenvue (KVUE.N), opens new tab cut its annual sales ...